| D007413 |
Intestinal Mucosa |
Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. |
Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal |
|
| D009767 |
Obesity, Morbid |
The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. |
Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity |
|
| D011218 |
Prader-Willi Syndrome |
An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229) |
Labhart-Willi Syndrome,Royer Syndrome,Labhart-Willi-Prader-Fanconi Syndrome,Prader Labhart Willi Syndrome,Prader-Labhart-Willi Syndrome,Royer's Syndrome,Willi-Prader Syndrome,Labhart Willi Prader Fanconi Syndrome,Labhart Willi Syndrome,Prader Willi Syndrome,Royers Syndrome,Syndrome, Labhart-Willi,Syndrome, Labhart-Willi-Prader-Fanconi,Syndrome, Prader-Labhart-Willi,Syndrome, Prader-Willi,Syndrome, Royer,Syndrome, Royer's,Syndrome, Willi-Prader,Willi Prader Syndrome |
|
| D004734 |
Energy Metabolism |
The chemical reactions involved in the production and utilization of various forms of energy in cells. |
Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy |
|
| D005260 |
Female |
|
Females |
|
| D005500 |
Follow-Up Studies |
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. |
Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
| D015904 |
Biliopancreatic Diversion |
A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass. |
Biliopancreatic Bypass,Bilio Pancreatic Bypasses,Bilio Pancreatic Diversions,Bilio-Pancreatic Bypass,Bilio-Pancreatic Diversion,Bilio Pancreatic Bypass,Bilio Pancreatic Diversion,Bilio-Pancreatic Bypasses,Bilio-Pancreatic Diversions,Biliopancreatic Bypasses,Biliopancreatic Diversions,Bypass, Bilio-Pancreatic,Bypass, Biliopancreatic,Bypasses, Bilio Pancreatic,Bypasses, Bilio-Pancreatic,Bypasses, Biliopancreatic,Diversion, Bilio Pancreatic,Diversion, Bilio-Pancreatic,Diversions, Bilio Pancreatic,Diversions, Bilio-Pancreatic,Diversions, Biliopancreatic,Pancreatic Bypasses, Bilio,Pancreatic Diversion, Bilio,Pancreatic Diversions, Bilio |
|
| D017211 |
Treatment Failure |
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. |
Failure, Treatment,Failures, Treatment,Treatment Failures |
|